approached significantp = 0.0592
At one standard deviation below average PTSD severity, performance approached significant worsening on tolcapone versus placebo (t(32.1) = −1.956, p = 0.0592, d = 0.6905), while at two standard deviations above average PTSD severity, performance approached significant improvement on tolcapone versus placebo (t(32.1) = 2.002, p = 0.0538, d = 0.7067).